Cargando...
A pharmacokinetic and pharmacodynamic drug interaction between rosuvastatin and valsartan in healthy subjects
PURPOSE: Valsartan, an angiotensin-receptor blocker, and rosuvastatin, a competitive inhibitor of the 3-hydroxy-3-methylglutaryl coenzyme A reductase, are frequently coadministered to treat patients with hypertension and dyslipidemia. The study reported here sought to evaluate the pharmacokinetic an...
Gardado en:
Publicado en: | Drug Des Devel Ther |
---|---|
Main Authors: | , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado: |
Dove Medical Press
2015
|
Assuntos: | |
Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4354399/ https://ncbi.nlm.nih.gov/pubmed/25767372 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S76942 |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|